A clinical trial to study the effects of two drugs to compare efficacy and safety between Diclofenac Sodium and Tramadol in post Cesarean delivery pain relief in patients of Preeclampsia

Randomized controlled single blind trial to compare efficacy and safety between Diclofenac Sodium and Tramadol in post LSCS analgesia in patients of Preeclampsia. - Nil

Status

Recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2013/02/003395

Enrollment

200

Registered

2013-02-14

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Analgesia in post LSCS patients with preeclampsia with routinely used analgesics (Tramadol - Opiod and Diclofenac - NSAID)

Interventions

Intervention1: Diclofenac: Injection Diclofenac Sodium : 75 mg im 8 hrly for 2 days followed by tablet Diclofenac Sodium 100 mg TDS for 5 days Control Intervention1: Tramadol: Injection Tramadol 100

Eligibility

Inclusion criteria

Inclusion criteria: Post LSCS patients with PE from PNC ward of Gynecology and Obstetrics Deptt ready to give informed consent.

Exclusion criteria

Exclusion criteria: 1.Patient with Eclampsia. 2.Patient with PE with Renal Failure. 3.Patient with PE with Cardiac decompensation. 4.Normotensive patients who underwent LSCS for other obstetric indications other than PE.

Design outcomes

Primary

Measure	Time frame
i) Efficacy and safety of Tramadol in post LSCS analgesia in Preeclampsia. ii) Efficacy and safety of Diclofenac Sodium in post LSCS analgesia in Preeclampsia. Timepoint: for 8 days during indoor period	—

Secondary

Measure	Time frame
i) Comparative study between these two for Efficacy and safety.Timepoint: for 8 days during indoor period	—

Countries

India

Contacts

Public ContactDr Ghodki Sarang Gajanan

Dr. Panjabrao Alias Bhausaheb Deshmukh Memorial Medical Colleg

pushpasj4@rediffmail.com91-9922445937

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026